James E. Gervasoni Jr., M.D.,

NPI 1396807145ActiveIndividual· Specialist· New Brunswick, NJ

Specialist (M.D.,) in New Brunswick, New Jersey, trained at Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc) (class of 1993). Mostly services rather than prescriptions: Medicare paid $12,552 for 32 patients in 2024, with only 16 Part D claims. Astrazeneca Pharmaceuticals LP was the largest of 3 companies reporting payments in 2025, $142.95 in all, mostly food and beverage.

Overview

NPI	1396807145
Status	Active
Entity type	Individual
Credential	M.D.,
Sole proprietor	No
NPI issued	Dec 15, 2006
Last updated in NPPES	Jul 8, 2007

Specialties and licenses

Taxonomy	Code	License	State
Specialist Primary	174400000X	MA7045600	NJ

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026	No match	—
New York OMIG · Nov 10, 2026	No match	—
Ohio Medicaid · Nov 10, 2026	No match	—
Pennsylvania Medicheck · Nov 10, 2026	No match	—
Washington HCA · Nov 10, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - General Surgery (NJ)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	32
Services billed	46 across 27 procedure codes
Paid by Medicare	$12,552

Part D prescriptions in 2024

Prescriptions (claims)	16 · 16 30-day fills
Patients	14
Total drug cost	$52.90
Generic share	88% of claims

Medicare sources and data years

Education and affiliations

Medical school	Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc)
Graduation year	1993
Medicare specialty	General Surgery
Secondary specialties	Surgical Oncology